RxDoctor Payments Data

Herbert McCowen, MD

Family Medicine · Overland Park, KSNPI 1902891823

Payments from drug & device makers

$8,653in general payments, 2019–2025

Across 518 payments — averaging $16.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • AstraZeneca$924
  • Lilly USA, LLC$793
  • Pfizer$702
  • Amgen$401
  • plus $3K from 42 others

What the payments were for

  • Food & beverage$8,653100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,653 in reported general payments places this provider in the 90th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$171,807
Medicare patients
321
Services billed
4,844

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide101$132,099
JardianceEmpagliflozin88$100,448
MounjaroTirzepatide55$68,487
FarxigaDapagliflozin Propanediol64$62,020
Repatha SureclickEvolocumab42$28,181
EliquisApixaban27$27,230
XareltoRivaroxaban16$22,414
MyrbetriqMirabegron27$19,968
Praluent PenAlirocumab20$16,005
TrulicityDulaglutide12$12,848
Spiriva HandihalerTiotropium Bromide12$10,097
Lantus SolostarInsulin Glargine,hum.Rec.Anlog70$7,818
SynthroidLevothyroxine Sodium82$6,263
Rosuvastatin Calcium451$5,054
Gabapentin231$4,151

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,048$132,099101 claims
Boehringer IngelheimJardiance$308$100,44888 claims
Lilly USA, LLCMounjaro, Trulicity$793$81,33467 claims
AstraZenecaFarxiga$924$62,02064 claims
PfizerEliquis$702$27,23027 claims
Johnson & JohnsonXarelto$117$22,41416 claims
Astellas Pharma US IncMyrbetriq$137$19,96827 claims
AbbVieSynthroid$1,478$6,26382 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$26$3,529464 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →